AXON Neuroscience R&D Services SE

Axon Neuroscience is an industry-leading clinical stage biotech company at the forefront of treating and preventing Alzheimer’s disease.

Axon’s mission is to eradicate Alzheimer’s disease by developing tau-based treatments that halt the disease and relieve symptoms in sufferers, as well as prevent onset in potential victims.

Axon Neuroscience has assembled an international team of leading experts in the field of neuroscience and clinical drug development to support the design, conduct, and analysis of Axon Neuroscience clinical trials for new treatments of Alzheimer’s disease and other related neurodegenerative disorders.

Founded in 1999, Axon now has the single biggest team in the world dedicated exclusively to tau protein research in relation to treating Alzheimer's disease and other tauopathies.